Co-Authors
This is a "connection" page, showing publications co-authored by XIAOPING SU and WARREN C FISKUS.
Connection Strength
0.480
-
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor. Blood. 2024 Feb 16.
Score: 0.247
-
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. Blood Cancer J. 2023 04 13; 13(1):53.
Score: 0.233